KPWG
ABBV icon

KFA Private Wealth Group’s AbbVie ABBV Stock Holding History

KFA Private Wealth Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$438K Sell
1,740
-167
-9% -$35.9K 0.11% 90
2026
Q1 		$415K Sell
1,907
-108
-5% -$24K 0.1% 96
2025
Q4 		$461K Buy
2,015
+231
+13% +$52.6K 0.11% 85
2025
Q3 		$413K Sell
1,784
-201
-10% -$40.9K 0.12% 80
2025
Q2 		$369K Sell
1,985
-110
-5% -$20.4K 0.11% 87
2025
Q1 		$439K Buy
2,095
+160
+8% +$31.1K 0.15% 67
2024
Q4 		$344K Buy
1,935
+217
+13% +$39.9K 0.14% 65
2024
Q3 		$339K Buy
1,718
+419
+32% +$78.2K 0.16% 59
2024
Q2 		$223K Sell
1,299
-1,060
-45% -$176K 0.12% 71
2024
Q1 		$430K Buy
2,359
+207
+10% +$35.7K 0.13% 69
2023
Q4 		$334K Buy
2,152
+8
+0.4% +$1.17K 0.12% 67
2023
Q3 		$320K Sell
2,144
-6
-0.3% -$881 0.13% 62
2023
Q2 		$290K Sell
2,150
-413
-16% -$60.6K 0.12% 65
2023
Q1 		$409K Buy
2,563
+694
+37% +$106K 0.19% 49
2022
Q4 		$302K Sell
1,869
-268
-13% -$41.1K 0.15% 51
2022
Q3 		$287K Sell
2,137
-13
-0.6% -$1.86K 0.15% 51
2022
Q2 		$329K Sell
2,150
-68
-3% -$10.4K 0.18% 48
2022
Q1 		$360K Buy
2,218
+7
+0.3% +$1.02K 0.18% 49
2021
Q4 		$299K Buy
2,211
+7
+0.3% +$827 0.15% 58
2021
Q3 		$238K Buy
2,204
+165
+8% +$18.9K 0.13% 66
2021
Q2 		$230K Buy
2,039
+121
+6% +$13.6K 0.13% 65
2021
Q1 		$208K Buy
1,918
+5
+0.3% +$535 0.12% 74
2020
Q4 		$205K Buy
+1,913
New +$184K 0.13% 69

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

KFA Private Wealth Group's ABBV Position: Q2 2026 in Review

KFA Private Wealth Group reduced its AbbVie (ABBV) stake by 8.8% in Q2 2026, selling an estimated $35.9K and leaving 1,740 shares worth $438K. The position accounts for 0.11% of the portfolio, ranked #90.

KFA Private Wealth Group first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $461K in Q4 2025. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • KFA Private Wealth Group held 1,740 shares of AbbVie worth $438K as of Q2 2026.
  • KFA Private Wealth Group sold 167 AbbVie shares in Q2 2026, an estimated $35.9K.
  • AbbVie made up 0.11% of KFA Private Wealth Group's portfolio in Q2 2026, its #90 holding.
  • KFA Private Wealth Group first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • KFA Private Wealth Group's AbbVie position peaked at $461K in Q4 2025.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on KFA Private Wealth Group's 13F filing for Q2 2026, filed 28 Jul 2026.